
    
      The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to
      monitor changes in the rate of mother to child transmission and preventive practices in
      France and especially to identify the occurrence of toxicity in children exposed perinatally
      to antiretroviral drugs.

      The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1
      maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM).

      Maternal clinical, biological and therapeutic data before and during pregnancy were collected
      at delivery, with simplified questionnaires.

      The children are examined clinically and biologically at birth, 6, 12 and 24 months.
    
  